Disclaimer
Biotec Pharmacon ASA. Company Head Office: Strandgata 3, N-9008 Tromsø, NORWAY
Telephone: (+47) 7764 8900 – Telefax: (+47) 7764 8901 E-mail: info@biotec.no
NO 959 033 560 MVA
All trademarks, service marks, and trade names of Biotec Pharmacon ASA expressly or indirectly defined as such on the web site are trademarks or registered trademarks of Biotec Pharmacon ASA or its affiliates, unless stated otherwise. You may not use, copy, reproduce, republish, upload, post, transmit, distribute, or modify our trademarks in any way, including, but not limited to, in advertising or publicity pertaining to distribution of materials on our web site, without our prior written consent. The use of our trademarks on any other web site or materials is prohibited without our express written consent. The list of ways to exploit the trademarks is not complete and all other, whether known or unknown, ways of exploitation of the trademarks are also prohibited.
Copyright© 1999-2009 Biotec Pharmacon ASA. The copyright in all content on this web site is owned by Biotec Pharmacon ASA. You may not modify any of the materials and you may not copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer, or sell any of the content. Except as authorized under copyright law, you may not reuse any content without first obtaining the consent of Biotec Pharmacon ASA. The list of ways to exploit the copyrights is not complete and all other, whether known or unknown, ways of exploitation of the copyrights are also prohibited.
Telephone: (+47) 7764 8900 – Telefax: (+47) 7764 8901 E-mail: info@biotec.no
NO 959 033 560 MVA
All trademarks, service marks, and trade names of Biotec Pharmacon ASA expressly or indirectly defined as such on the web site are trademarks or registered trademarks of Biotec Pharmacon ASA or its affiliates, unless stated otherwise. You may not use, copy, reproduce, republish, upload, post, transmit, distribute, or modify our trademarks in any way, including, but not limited to, in advertising or publicity pertaining to distribution of materials on our web site, without our prior written consent. The use of our trademarks on any other web site or materials is prohibited without our express written consent. The list of ways to exploit the trademarks is not complete and all other, whether known or unknown, ways of exploitation of the trademarks are also prohibited.
Copyright© 1999-2009 Biotec Pharmacon ASA. The copyright in all content on this web site is owned by Biotec Pharmacon ASA. You may not modify any of the materials and you may not copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer, or sell any of the content. Except as authorized under copyright law, you may not reuse any content without first obtaining the consent of Biotec Pharmacon ASA. The list of ways to exploit the copyrights is not complete and all other, whether known or unknown, ways of exploitation of the copyrights are also prohibited.
News
- Patent granted in USAMay 28,2010A composition patent protecting combinations of Biotec Pharmacon’s proprietary compound soluble yeast beta-glucan (SBG) as an adjuvant together with monoclonal antibodies for treatment of cancer has been granted in the U.S.
- Q1-2010 Presentation as WebCastApril 29,2010Biotec Phamacon will present its report for Q1 2010 on May 11th at 09:00. The presentation will be held at Thon Conference Vika Atrium, Oslo. The presentation will also be available as webcast.
- Ordinary General MeetingApril 13,2010The Board of Directors has today given notice of ordinary general meeting in Biotec Pharmacon to be held May 4th, 2010, at 15:00. The meeting will be held at the company's premises in Strandgata 3, Tromsø, Norway.